Maria del Pilar Lopez Pazmino

Maria del Pilar Lopez Pazmino

Auto-generated profile, based on publicly available information

Maria del Pilar Lopez Pazmino

Cell Design Institute, Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2021 in Science
Verified
Journal Article
Closed access
RHRogelio A. Hernandez-Lopez
Rogelio A. Hernandez-Lopez
WYWei Yu
Wei Yu
KCKatelyn A. Cabral
Katelyn A. Cabral
OCOlivia A. Creasey
Olivia A. Creasey
MPMaria del Pilar Lopez Pazmino
Maria del Pilar Lopez Pazmino
WLWendell A. Lim
Wendell A. Lim
Designing smarter anticancer T cells: Biological signaling systems can exhibit a large, nonlinear—or “ultrasensitive”—response, which would be useful to engineer into therapeutic T cells to allow for better discrimination between cancer cells and normal tissues. Hernandez-Lopez et al. modified human T cells using a two-step mechanism that allowed them to kill cells expressing large amounts of cancer marker protein but not cells expressing a small amount of the same protein. A first synthetic receptor recognized the antigen with low affinity. That receptor signaled to increase expression of a chimeric antigen receptor (CAR) with high affinity for the same antigen. The circuit proved effective in cell culture and mouse cancer models, offering hope of extending the CAR T cell strategy against solid tumors. Science , this issue p. 1166

16 October 2020 in Science
Verified
Journal Article
Closed access
STSatoshi Toda
Satoshi Toda
WMWesley L. McKeithan
Wesley L. McKeithan
THTeemu J. Hakkinen
Teemu J. Hakkinen
PLPilar Lopez
Pilar Lopez
OKOphir D. Klein
Ophir D. Klein
WLWendell A. Lim
Wendell A. Lim
Engineering synthetic morphogens: Morphogens provide positional information during tissue development. For this behavior to occur, morphogens must spread out and form a concentration gradient; however, their mechanism of transport remains a matter of debate. Stapornwongkul et al. now show that in the presence of extracellular binding elements (binders), the inert green fluorescent protein (GFP) can form a detectable concentration gradient by diffusion in the developing fly wing (see the Perspective by Barkai and Shilo). When combining the expression of nonsignaling binders and receptors engineered to respond to GFP, a synthetic GFP gradient can substitute for a natural morphogen to organize growth and patterning. In related work, Toda et al. also show that GFP can be converted into a morphogen by providing anchoring interactions that tether the molecule, forming a gradient that can be recognized by synthetic receptors that activate gene expression. These synthetic morphogens can be used to program de novo multidomain tissue patterns. These results highlight core mechanisms of morphogen signaling and patterning and provide ways to program spatial tissue organization independently from endogenous morphogen pathways. Science , this issue p. 321 , p. 327 ; see also p. 292